Turkey Generics 麻豆原创 Summary, Competitive Analysis and Forecast, 2017-2026
Summary
Generics in Turkey industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Turkish generics market had total revenues of $2.4bn in 2021, representing a compound annual growth rate (CAGR) of 29% between 2016 and 2021.
- 麻豆原创 consumption volume increased with a CAGR of 1.5% between 2016 and 2021, to reach a total of 62.4 % in 2021.
- Over the past five years, the Turkish market recorded growth of 27.2%. Growth in the market has been driven by demographic trends alongside strong supply-side infrastructure.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Turkey
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Turkey
- Leading company profiles reveal details of key generics market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Turkey generics market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Turkey generics market by value in 2021?
- What will be the size of the Turkey generics market in 2026?
- What factors are affecting the strength of competition in the Turkey generics market?
- How has the market performed over the last five years?
- What are the main segments that make up Turkey's generics market?
Table of Contents
1 Executive Summary
1.1. 麻豆原创 value
1.2. 麻豆原创 value forecast
1.3. 麻豆原创 volume
1.4. 麻豆原创 volume forecast
1.5. Geography segmentation
1.6. 麻豆原创 rivalry
1.7. Competitive Landscape
2 麻豆原创 Overview
2.1. 麻豆原创 definition
2.2. 麻豆原创 analysis
3 麻豆原创 Data
3.1. 麻豆原创 value
3.2. 麻豆原创 volume
4 麻豆原创 Segmentation
4.1. Geography segmentation
5 麻豆原创 Outlook
5.1. 麻豆原创 value forecast
5.2. 麻豆原创 volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How did the COVID-19 pandemic impact leading players?
8 Company Profiles
8.1. Deva Holding AS
8.2. Pfizer Inc.
8.3. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
8.4. Nobelpharma Co Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related 麻豆原创Line research
10.4. About 麻豆原创Line
List of Tables
List of Tables
Table 1: Turkey generics market value: $ million, 2016-21
Table 2: Turkey generics market volume: %, 2016-21
Table 3: Turkey generics market geography segmentation: $ million, 2021
Table 4: Turkey generics market value forecast: $ million, 2021-26
Table 5: Turkey generics market volume forecast: %, 2021-26
Table 6: Deva Holding AS: key facts
Table 7: Deva Holding AS: Annual Financial Ratios
Table 8: Deva Holding AS: Key Employees
Table 9: Pfizer Inc.: key facts
Table 10: Pfizer Inc.: Annual Financial Ratios
Table 11: Pfizer Inc.: Key Employees
Table 12: Pfizer Inc.: Key Employees Continued
Table 13: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: key facts
Table 14: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Employees
Table 15: Nobelpharma Co Ltd: key facts
Table 16: Nobelpharma Co Ltd: Key Employees
Table 17: Nobelpharma Co Ltd: Key Employees Continued
Table 18: Turkey size of population (million), 2017-21
Table 19: Turkey gdp (constant 2005 prices, $ billion), 2017-21
Table 20: Turkey gdp (current prices, $ billion), 2017-21
Table 21: Turkey inflation, 2017-21
Table 22: Turkey consumer price index (absolute), 2017-21
Table 23: Turkey exchange rate, 2017-21
List of Figures
List of Figures
Figure 1: Turkey generics market value: $ million, 2016-21
Figure 2: Turkey generics market volume: %, 2016-21
Figure 3: Turkey generics market geography segmentation: % share, by value, 2021
Figure 4: Turkey generics market value forecast: $ million, 2021-26
Figure 5: Turkey generics market volume forecast: %, 2021-26
Figure 6: Forces driving competition in the generics market in Turkey, 2021
Figure 7: Drivers of buyer power in the generics market in Turkey, 2021
Figure 8: Drivers of supplier power in the generics market in Turkey, 2021
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Turkey, 2021
Figure 10: Factors influencing the threat of substitutes in the generics market in Turkey, 2021
Figure 11: Drivers of degree of rivalry in the generics market in Turkey, 2021
Deva Holding AS
Pfizer Inc.
Abdi Ibrahim Ilac Sanayi ve Ticaret AS
Nobelpharma Co Ltd
听
听
*If Applicable.